` 688336 (Sunshine Guojian Pharmaceutical Shanghai Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

S
688336
vs
S
Shanghai Composite

Over the past 12 months, Sunshine Guojian Pharmaceutical Shanghai Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +165% compared to the Shanghai Composite's +23% growth.

Stocks Performance
688336 vs Shanghai Composite

Loading
688336
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688336 vs Shanghai Composite

Performance Gap Between 688336 and SSEC
HIDDEN
Show

Performance By Year
688336 vs Shanghai Composite

Loading
688336
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sunshine Guojian Pharmaceutical Shanghai Co Ltd vs Peers

Shanghai Composite
688336
RYI
AVGR
BROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Glance View

Market Cap
36.6B CNY
Industry
Biotechnology

Sunshine Guojian Pharmaceutical Shanghai Co., Ltd. stands as a beacon of innovation in China’s bustling pharmaceutical landscape. Born from a vision to advance biotech research and development, the company has centered its efforts on the creation of monoclonal antibody drugs. These biologics are pivotal in treating complex diseases such as cancers and autoimmune disorders, positioning Sunshine Guojian at the forefront of biopharmaceutical excellence. The company's prowess is anchored in its robust R&D capabilities, with a specialized team of scientists and cutting-edge facilities driving the creation of therapeutics that meet global standards. By strategically focusing on biologics, the firm not only taps into a growing demand for advanced medical solutions but also strengthens its competitive edge in both domestic and international markets. The economic engine of Sunshine Guojian hums along with a well-oiled strategy of clinical development and commercialization. Partnering with healthcare professionals and institutions, the company ensures that its biologics are effectively integrated into treatment paradigms, thereby enhancing patient care and outcomes. Revenue streams flow through a mix of direct sales and strategic partnerships, both within China and abroad, where collaborative alliances help broaden market reach and drive scale. Moreover, its established networks enable the company to stay attuned to emerging medical needs and regulatory environments, adapting swiftly to maintain its leadership position. This adeptness in maneuvering the complex web of pharmaceutical offerings allows Sunshine Guojian not just to survive but to thrive, fueling sustainable growth and innovation in an ever-evolving health landscape.

Sunshine Guojian Pharmaceutical Shanghai Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top